Benefits and risks of switching from protease inhibitors to nevirapine with stable background therapy in patients with low or undetectable viral load: a multicentre study-Reference-Cited by-同舟云学术

Benefits and risks of switching from protease inhibitors to nevirapine with stable background therapy in patients with low or undetectable viral load: a multicentre study

Published:2000-07 Issue:11 Volume:14 Page:1655-1656
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:AIDS

Author:

Luca Andrea De,Baldini Francesco,Cingolani Antonella,Giambenedetto Simona Di,Zaccarelli Mauro,Tozzi Valerio,Ammassari Adriana,Murri Rita,Antinori Andrea

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference9 articles.

1. Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

2. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

3. Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study

4. Maintenance Antiretroviral Therapies in HIV-Infected Subjects with Undetectable Plasma HIV RNA after Triple-Drug Therapy

5. A Randomized Trial of Three Maintenance Regimens Given after Three Months of Induction Therapy with Zidovudine, Lamivudine, and Indinavir in Previously Untreated HIV-1–Infected Patients

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV Therapeutics: Antiretroviral Drugs and Immune-Based Therapies;National Institute of Allergy and Infectious Diseases, NIH;2009

2. Management of Antiretroviral Treatment–Related Complications;Infectious Disease Clinics of North America;2007-03

3. Tolerability and Safety of HIV Protease Inhibitors in Adults;JAIDS Journal of Acquired Immune Deficiency Syndromes;2004-09

4. Management of Metabolic Complications Associated With Antiretroviral Therapy for HIV-1 Infection: Recommendations of an International AIDS Society–USA Panel;JAIDS Journal of Acquired Immune Deficiency Syndromes;2002-11

5. Low Risk of Treatment Failure after Substitution of Nevirapine for Protease Inhibitors among Human Immunodeficiency Virus–Infected Patients with Virus Suppression;The Journal of Infectious Diseases;2002-05